![Thomas Schall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Schall
Presidente presso
IMMUNEERING CORPORATION
Patrimonio netto: 371 905 $ in data 30/06/2026
Profilo
Thomas J.
Schall was the founder of ChemoCentryx, Inc., founded in 1997, where the titles held included Chairman, President & Chief Executive Officer from 2012 to 2022.
The current job is Chairman at Immuneering Corp., starting in 2025.
Former jobs include Scientist at Genentech, Inc., and Principal at DNAX Research, Inc. from 1993 to 1997.
Education includes a doctorate from Stanford University and an undergraduate degree from Northern Illinois University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/06/2026 | 74.530 ( 0,12% ) | 371 905 $ | 30/06/2026 |
Posizioni attive di Thomas Schall
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNEERING CORPORATION | Presidente | 16/09/2025 |
Precedenti posizioni note di Thomas Schall
| Società | Posizione | Fine |
|---|---|---|
| CHEMOCENTRYX, INC. | Amministratore Delegato | 20/10/2022 |
DNAX Research, Inc. | Corporate Officer/Principal | 01/01/1997 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Thomas Schall
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
55
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northern Illinois University
 Northern Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DNAX Research, Inc. | |
Immuneering Corp.
 Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
